What is the treatment for a 12-year-old female with a UTI (Urinary Tract Infection) caused by Streptococcus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Symptomatic UTI with Viridans Streptococcus in a 12-Year-Old Female

For a 12-year-old female with persistent UTI symptoms and culture-confirmed viridans streptococcus (>100,000 CFU/mL), treat with penicillin or amoxicillin as first-line therapy, as viridans streptococci are typically highly susceptible to beta-lactam antibiotics.

Antibiotic Selection and Rationale

  • Penicillin-based antibiotics (penicillin V or amoxicillin) are the drugs of choice for viridans streptococcal UTI, as these organisms maintain excellent susceptibility to beta-lactams 1.

  • Amoxicillin 20-40 mg/kg/day divided into three doses for 7-10 days is appropriate for pediatric UTI treatment, though specific data for viridans streptococcus is limited 2, 3.

  • Avoid trimethoprim-sulfamethoxazole for prolonged treatment of streptococcal UTI, as resistance can develop rapidly even when organisms initially appear sensitive, particularly with Streptococcus faecalis (a related organism) 1.

Important Clinical Considerations

This is NOT Asymptomatic Bacteriuria

  • Since this patient has persistent symptoms, treatment is indicated 4. The IDSA guidelines strongly recommend against treating asymptomatic bacteriuria in healthy children, but this patient is symptomatic 4.

  • The distinction between symptomatic infection and asymptomatic bacteriuria is critical, as treatment of asymptomatic bacteriuria provides no benefit and causes harm through antibiotic resistance and adverse effects 4.

Unusual Organism Warrants Further Evaluation

  • Viridans streptococcus is an uncommon uropathogen in children, as E. coli causes approximately 75% of UTIs 4. This unusual organism should prompt consideration of:

    • Structural or functional urinary tract abnormalities 4
    • Voiding dysfunction 4
    • Recent instrumentation or catheterization 4
  • If symptoms persist after appropriate antibiotic therapy or if this represents recurrent infection (≥3 episodes in 12 months), imaging evaluation may be warranted to exclude anatomic abnormalities 4.

Treatment Duration and Monitoring

  • Use a 7-10 day course rather than short-course therapy, as the evidence for 3-5 day treatment applies primarily to E. coli cystitis in adult women 5, 2, 3.

  • Confirm eradication with negative urine culture 1-2 weeks after completing treatment if symptoms persist or recur 4.

Prevention Strategies if Recurrent

If this represents recurrent UTI (≥3 episodes in 12 months), implement behavioral modifications before considering antibiotic prophylaxis 4, 5:

  • Ensure adequate hydration to promote frequent urination 4, 5
  • Encourage regular, urge-initiated voiding and avoid prolonged holding of urine 4, 5
  • Maintain proper perineal hygiene 4

Common Pitfalls to Avoid

  • Do not use fluoroquinolones as first-line therapy in children due to concerns about musculoskeletal adverse effects and increasing resistance rates 2, 3.

  • Do not use nitrofurantoin or fosfomycin as first-line for streptococcal UTI, as these agents are optimized for gram-negative organisms and may have suboptimal activity against streptococci 2, 3, 6.

  • Do not treat based on dipstick or urinalysis alone without culture confirmation, especially with an unusual organism like viridans streptococcus 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Recurrent Pan-Sensitive E. coli UTIs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of urinary tract infections across age groups.

American journal of obstetrics and gynecology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.